This video feature is produced by Medicine Matters diabetes and is not supplied or sanctioned by the American Diabetes Association (ADA).
The educational content contained herein reflects the personal opinion of the experts.
Jay Shubrook declares the following relationships over the past 36 months:
- Grants/research support: AstraZeneca and Takeda
- Consulting or advisory role: Intarcia Therapeutics, Novo Nordisk, and Lilly Diagnostics
David Strain declares the following relationships over the past 36 months:
- Grants/research support: Novo Nordisk, Takeda, Novartis, Astra-Zeneca.
- Honoraria: Novo Nordisk, Novartis, Boehringer Ingelheim, Janssen, Eli Lilly, Merck, Pfizer, BMS.
- Consulting or advisory role: Novartis, Novo-Nordisk.
- Travel, accommodations, expenses: Astra Zeneca, Novartis.